Comparison of nintedanib-induced gastrointestinal adverse events in patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias

被引：0
|
作者：
Imai, Miyu [1 ]
Okabayashi, Hiroko [1 ]
Akaike, Kimitaka [1 ]
Hamada, Shohei [1 ]
Masunaga, Aiko [1 ]
Ichiyasu, Hidenori [1 ]
Sakagami, Takuro [1 ]
机构：
[1] Kumamoto Univ Hosp, Resp Med, Kumamoto, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP16-506
引用
收藏
页码：408 / 409
页数：2
相关论文
共 50 条
  • [21] Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Brunborg, Cathrine
    Airo, Paolo
    Ananieva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Kowal-Bielecka, Otylia
    Riccardi, Antonella
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 219 - 227
  • [22] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [23] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249
  • [24] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [25] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [26] Lung transplantation for systemic sclerosis-associated interstitial lung disease
    Le Pavec, J.
    Launay, D.
    Cottin, V.
    Reynaud-Gaubert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 : E73 - E79
  • [27] Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
    Allanore, Yannick
    Vonk, Madelon C.
    Distler, Oliver
    Azuma, Arata
    Mayes, Maureen D.
    Gahlemann, Martina
    James, Alexandra
    Kohlbrenner, Veronika
    Alves, Margarida
    Khanna, Dinesh
    Highland, Kristin B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1722 - 1729
  • [28] Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
    Seibold, James R.
    Maher, Toby M.
    Highland, Kristin B.
    Assassi, Shervin
    Azuma, Arata
    Hummers, Laura Kathleen
    Costabel, Ulrich
    von Wangenheim, Ute
    Kohlbrenner, Veronika
    Gahlemann, Martina
    Alves, Margarida
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1478 - 1484
  • [29] Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
    Smith, Vanessa
    Denton, Christopher
    Herrick, Ariane
    Ittrich, Carina
    Alves, Margarida
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1241 - 1243
  • [30] THE STUDY OF NINTEDANIB EFFICACY IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Desinova, Oxana
    Shayakhmetova, Rushana
    CHEST, 2023, 164 (04) : 5480A - 5481A
12345